Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
Holding APVO?
Track your performance easily

Aptevo Therapeutics (APVO) Financial Statements

444 Followers

Aptevo Therapeutics Financial Overview

Aptevo Therapeutics's market cap is currently ―. The company's EPS TTM is $-25.447; its P/E ratio is -0.01; Aptevo Therapeutics is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.10M$ -5.88M$ -6.83M$ -6.38M$ -6.56M
EBITDA$ -5.02M$ -5.79M$ -6.73M$ -6.27M$ -6.44M
Net Income Common Stockholders$ -5.10M$ -5.88M$ -6.83M$ -5.90M$ -6.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.75M$ 8.07M$ 10.25M$ 16.90M$ 19.11M
Total Assets$ 15.15M$ 14.92M$ 17.63M$ 24.84M$ 27.13M
Total Debt$ 4.80M$ 5.00M$ 5.20M$ 5.40M$ 5.60M
Net Debt$ -2.95M$ -3.07M$ -5.05M$ -11.50M$ -13.51M
Total Liabilities$ 10.73M$ 10.43M$ 11.53M$ 12.62M$ 12.41M
Stockholders Equity$ 4.42M$ 4.46M$ 6.10M$ 12.22M$ 14.72M
Cash Flow-
Free Cash Flow$ -5.22M$ -6.15M$ -6.65M$ -5.25M$ -6.24M
Operating Cash Flow$ -5.22M$ -6.15M$ -6.65M$ -5.25M$ -6.24M
Investing Cash Flow-----
Financing Cash Flow$ 4.91M$ 3.97M$ -3.00K$ 3.05M$ 4.34M
Currency in USD

Aptevo Therapeutics Earnings and Revenue History

Aptevo Therapeutics Debt to Assets

Aptevo Therapeutics Cash Flow

Aptevo Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis